Molecular prognostic profile of egyptian HCC cases infected with hepatitis C virus

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5433-5438

  Zekri, Abdel Rahman N ^a   Hassan, Zeinab K ^a   Bahnassy, Abeer A ^b   Sherif, Ghada M ^c   ELdahshan, Dina ^d   Abouelhoda, Mohamed ^e,f   Ali, Ahmed ^e   Hafez, Mohamed M ^a  

^a Virology and Immunology Unit   (Egypt)

^b Pathology Department   (Egypt)

^c NATIONAL CANCER INSTITUTE   (Egypt)

^d Faculty of Medicine   (Egypt)

^e NILE UNIVERSITY   (Egypt)

^f CAIRO UNIVERSITY   (Egypt)

Author keywords

Egyptian hcc; Gene expression profile; Hepatitis C virus; Microarrays

Indexed keywords

EID: 84874083742     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5433     Document Type: Article

References (26)

1. Altekruse SF, McGlynn KA, Reichman ME (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975-2005. J Clin Oncol, 27, 1485-91.
2. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA (2008). Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res, 659, 176-84.
3. Castello G, Costantini S, Scala S (2010). Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment. J Transl Med, 8, 109.
4. Chang ML, Yeh CT, Chen JC, et al (2008). Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics, 9, 109.
5. Ciccaglione AR, Marcantonio C, Tritarelli E, et al (2008). Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones. BMC Genomics, 9, 309.
6. El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76.
7. Elam MB, Cowan GS, Rooney RJ, et al (2009). Hepatic gene expression in morbidly obese women: implications for disease susceptibility. Obesity (Silver Spring), 17, 1563-73.
8. Fassio E (2010). Hepatitis C and hepatocellular carcinoma. Ann Hepatol, 9, 119-22.
9. Harvey CE, Post JJ, Palladinetti P, et al (2003). Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol, 74, 360-9.
10. Hu C, Li H, Li J, et al (2008). Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling. Carcinogenesis, 29, 2289-97.
11. Kao JH, Chen PJ, Lai MY, Chen DS (2002). Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol, 40, 4068-71.
12. Kapadia SB, Chisari FV (2005). Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA, 102, 2561-6.
13. London WT, Evans AA, McGlynn K, et al (1995). Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology, 38, 155-61.
14. McGivern DR, Lemon SM (2011). Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene, 30, 1969-83.
15. Prasanthi JR, Huls A, Thomasson S, et al (2009). Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener, 4, 1.
16. Ryder SD (2003). Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut, 52, 1-8.
17. Singh R, Kaushik S, Wang Y, et al (2009). Autophagy regulates lipid metabolism. Nature, 458, 1131-5.
18. Su AI, Pezacki JP, Wodicka L, et al (2002). Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA, 99, 15669-74.
19. Wang K, Song Y, Chen DB, Zheng J (2008). Protein phosphatase 3 differentially modulates vascular endothelial growth factorand fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells. Biol Reprod, 79, 704-10.
20. Wang S, Tang H, He F, et al (2006). On the role of liver-enriched transcription factors in regulating HBV transcription and replication. Sichuan Da Xue Xue Bao Yi Xue Ban, 37, 35-9.
21. Yamashita T, Honda M, Kaneko S (2011). Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection. J Gastroenterol Hepatol, 26, 960-4.
22. Yu MC, Yuan JM (2004). Environmental factors and risk for hepatocellular carcinoma. Gastroenterology, 127, 72-8.
23. Zekri AR, Bahnassy AA, Abdel-Wahab SA, et al (2009). Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4. J Gastroenterol Hepatol, 24, 416-28.
24. Zekri AR, Bahnassy AA, Shaarawy SM, et al (2000). Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. J Med Microbiol, 49, 89-95.
25. Zekri AR, Hafez MM, Bahnassy AA, et al (2008). Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study. BMC Res Notes, 1, 106.
26. Zen Y, Fujii T, Yoshikawa S, et al (2007). Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol, 170, 1750-62.